There are ten studies for the outcome used here, memory measures, and the y i are standardised mean differences of treatment versus placebo with positive values of y i indicating that the treatment is beneficial.
The convergent validity is evaluated using the average variance extracted: AVE = (∑λ i )/(∑λ i ) + (∑v [δ i ]); where λ i = completely standardised factor loading for item i; ∑v [δ i ] = completely standardised error variance for item i. *) Passive behaviour: the scale values were reversed so that high scores reflect high levels of health motivation.
We believe that in the absence of (i) KRAS standardised testing procedures and (ii) sufficient data on the functional role of rare variants, a comprehensive analysis to identify all KRAS mutations in tumour samples is required.
Weber et al (1998) showed that Lektinol®, a towards ML-I content standardised mistletoe extract, inhibited lung colonisation of i.v. injected melanoma cells at a 30 ng ML-I per kg body weight equivalent dosage, while higher doses were less effective.
This inconsistency may be linked to differences in satisfaction instruments used (i.e. standardised vs. non-standardised), client profiles (e.g. the larger study included men only) and the small sample sizes in the two studies that found no differences in satisfaction ratings (N < 50).
The instruments (i.e. standardised questionnaire, standardised medical diagnostic procedure, assessment of exposure) used in this survey have been used in a similar form in other studies by several authors.
All instruments and techniques to be used in all centres will be standardised, i.e. equipment and training will be provided to each of the measurement teams.
Individual variables were standardised (i.e. z scores were computed: z = [value − mean]/SD), after normalising (log10) triacylglycerol, glucose and insulin.
Scanning protocols are also standardised, i.e. scans are performed at 60 ± 10 min after [F]FDG administration and all patients must undergo a pre- and post-treatment scan, for quantitative analysis.
The other session was a control condition during which mineral water consumption was standardised (i.e. 500 ml at meal time points and 250 ml at snack and hydration time points) to achieve a total daily intake of 2 litres on day 1, provided as indicated in Fig. 1.
